FDA Requires Label Change for Novartis AG, Roche Holding AG, and Wyeth’s Transplant Drugs

Reuters -- The U.S. Food and Drug Administration said on Tuesday it will require Novartis AG, Roche Holding AG and other makers of drugs to prevent transplanted organ rejection to add information to product labels about the risk of infections.